IGM Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IGMS and buy or sell other stocks, ETFs, and their options commission-free!

About IGMS

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. 

CEO
Mary Beth Harler
CEOMary Beth Harler
Employees
149
Employees149
Headquarters
Mountain View, California
HeadquartersMountain View, California
Founded
2010
Founded2010
Employees
149
Employees149

IGMS Key Statistics

Market cap
78.71M
Market cap78.71M
Price-Earnings ratio
-1.39
Price-Earnings ratio-1.39
Dividend yield
—
Dividend yield—
Average volume
233.73K
Average volume233.73K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$22.39
52 Week high$22.39
52 Week low
$0.944
52 Week low$0.944

People also own

Based on the portfolios of people who own IGMS. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
Plug Power
Tilray Brands
Lucid Group
Workhorse
Virgin Galactic Holdings
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.